Previous studies have used VEGF inhibitors to treat hypertension, proteinuria, glomerular endothelial injury, elevated circulating liver enzymes, cerebral oedema, and other related conditions, similar to those of PE and eclampsia in humans. The gene discussed is VEGFA; the disease is brain edema.